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does when it is located in its more 
familiar perch on the plasma mem-
brane. Indeed, if it were located on the 
lumen of the ER/Golgi and acted in its 
usual manner, one would expect that, 
as the Ca2+ stores in the Golgi or ER 
reached their highest concentrations, 
the CaR would be activated, generate 
IP3, which would bind to IP3R on the ER 
or Golgi membrane, and stimulate Ca2+ 
release from these Ca2+ stores. Thus, 
overexpression, not deletion, would 
lead to emptying of these Ca2+ stores, 
opposite the findings in this report. The 
findings that CaR deletion instead leads 
to Ca2+ store emptying suggest that CaR 
either interacts directly with these pro-
teins to modulate Ca2+ ATPase activity 
or acts separately to directly inhibit Ca2+ 
release or escape from these Ca2+ stores. 
The authors propose that CaR acts as 
a feedback mechanism to maintain 
the proper level of Ca2+ filling in these 
stores. Previous work by these authors 
demonstrates that CaR splicing and Ca2+ 
levels differ markedly in keratinocytes 
depending on their differentiation state. 
It may be that optimal Ca2+ store levels 
also fluctuate depending on differentia-
tion and that CaR senses the cytosolic 
or luminal Ca2+ and determines the 
appropriate level of Ca2+ sequestration. 
Because Ca2+ sequestration also deter-
mines Ca2+ influx, via store-operated 
Ca2+ entry, intracellular CaR signaling 
may maintain store and cytosolic Ca2+ 
concentrations at levels appropriate for 
each stage of differentiation. Finally, 
phospholipase Cγ1 and IP3R each act at 
many different sites, including directly 
on ion channels (Patterson et al., 2002). 
How their functions differ when com-
plexed to CaR is unknown, but it is pos-
sible that CaR exerts additional effects 
via its actions on phospholipase Cγ1 
and/or IP3R. Answers to these questions 
await further studies.
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Enzymes of the cytochrome P450 (CYP) superfamily are the most versatile and 
important class of drug-metabolizing enzymes, involved in the metabolism of 
xenobiotics to which human skin is exposed. Bergström et al. used a recombi-
nant human CYP cocktail in ratios that simulate those found in human skin for 
the purpose of identifying prohapten metabolites of otherwise inert molecules.
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Enzymes of the cytochrome P450 (CYP) 
superfamily serve numerous impor-
tant roles in the health, damage, and 
function of skin (Ahmad and Mukhtar, 
2004). The CYPs are the most important 
among the drug-metabolizing enzymes 
in the skin by virtue of their crucial role 
in controlling the steady-state concen-
trations of a variety of bioactive sub-
stances (Mukhtar and Khan, 1989). The 
primary role of CYP enzymes is to par-
ticipate in metabolic transformation of 
not only endogenous substrates (fatty 
acids, eicosanoids, sterols, steroids, 
vitamin A, and vitamin D) but also 
xenobiotic materials (such as pollut-
ants, cigarette smoke, and other exog-
enous compounds) to which human 
skin is either deliberately or inadver-
tently exposed. The xenobiotics that 
come into contact with the skin can be 
biotransformed into harmless or less 
harmful agents by enzymatic reactions 
catalyzed by a variety of metabolizing 
enzymes, including CYPs present in the 
skin (Ahmad and Mukhtar, 2004). This 
ability to metabolize agents that diffuse 
through it is part of what constitutes 
the barrier function of the skin, and it 
leads to altered biological activities of 
the original compounds. This biotrans-
formation, however, can result in either 
degradation or activation, the latter 
of which may result in skin sensitiza-
tion or even carcinogenesis. In addi-
tion, because they can modulate drug 
bioavailability in the skin, the CYPs 
are important targets to be considered 
in drug development for skin disease. 
For this reason, a proper understand-
ing of the mechanisms involved in the 
biotransformation of endogenous and 
exogenous substrates by CYP in the 
skin is of utmost importance.
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 Human CYP cocktail 
provides a simplifi ed 
alternative method in 
mechanistic studies 
of CYP-mediated skin 
metabolism.
Allergic contact dermatitis is a com-
mon occupational and environmental 
health problem caused by chemicals 
that come in close contact with the skin. 
It has been reported that Europeans 
are commonly sensitized to one or 
more chemicals, and it is important to 
identify and evaluate the sensitizing 
potency of chemical allergens to pro-
vide precise risk assessments regarding 
their safe use. Once an individual has 
become sensitized, the allergy remains 
throughout life, because no restorative 
therapy is known. To thwart allergic 
contact dermatitis, exposure to the 
allergenic compound must be avoided. 
Thus, it is important to identify chemi-
cal allergens and evaluate their sensi-
tizing potency. Most contact allergens 
contain electrophilic functional groups 
that can react with nucleophilic amino 
acids in proteins via polar reaction 
mechanisms (Roberts and Lepoittevin, 
1998). On the contrary, there is also a 
group of contact allergens that seems 
to act through nonpolar mechanisms 
(Rosenkranz et al., 1999). Some of 
these sensitizing but protein-unreactive 
compounds are activated into reactive 
products and are referred to as pro-
haptens. There is a great interest in the 
development of methods for the pre-
diction of contact allergenic activity. 
Most methods of identifying allergens 
do not take into account the possible 
activation of prohaptens to sensitiz-
ers by skin metabolism. As a conse-
quence, consumer products undergo 
prolonged and expensive safety test-
ing in an attempt to eliminate allergic 
contact dermatitis. To identify pro-
haptens, studies regarding their struc-
ture–ctivity relationships and the 
mechanisms of their activation must be 
conducted. At present the murine local 
lymph node assay is the method of 
choice for identification and potency 
assessment of contact allergens (Kimber 
et al., 1995). The other alternative tech-
niques include cell-based assays (Ryan 
et al., 2001), chemical reactivity assays 
(Gerberick et al., 2004), and in silico 
methods (Fedorowicz et al., 2005). 
Development of a robust ex vivo or in 
vitro human enzyme-based assay for 
identification of prohaptens is required 
to streamline and increase the predic-
tive efficiency of current safety test 
methods and, importantly, to make 
animal models such as the local lymph 
node assay unnecessary.
Alternative methods that do not 
take skin metabolism into account 
will not detect prohaptens as sensitiz-
ers. Previous study has shown that the 
conjugated diene (5R)-5-isopropenyl-
2-methyl-1-methylene-2-cyclohexene 
is a prohapten, and its allergenic activ-
ity is exerted by metabolic conversion 
of the diene into two sensitizing epox-
ides: an endocyclic epoxide and an 
exocyclic epoxide in liver microsomes 
(Nilsson et al., 2005). Bergström and 
co-workers (2007, this issue) used 
human CYP enzymes in a cocktail in 
ratios appropriate to the human skin. It 
is suggested that the metabolites gen-
erated this way would resemble those 
expected in the skin. The approach is 
creative and challenging compared 
with work performed on liver tissue, 
with its high abundance of multiple 
CYPs and other enzymes. In doing this 
the authors concentrated the skin CYP 
1,000-fold in order to obtain reliable 
measurements of metabolite output. 
It is also suggested that the keratino-
cytes prepared from human skin might 
generate a microenvironment contain-
ing these metabolites. It is important 
to use keratinocytes and keratinocyte 
CYP, as they are the first cell type to 
encounter a potential allergy. The 
skin-like recombinant human CYP 
cocktail provides a simplified alter-
native method for using skin tissue 
preparations in mechanistic studies 
of CYP-mediated skin metabolism of 
prohaptens and offers the future pos-
sibility of designing in vitro predictive 
assays for assessment of allergenic 
activity of prohaptens. This study is 
a nice beginning to take our existing 
understanding of cutaneous metabo-
lism to an important new level that 
may lead to some very practical appli-
cations in the area of contact allergy 
and product development.
In the follow-up studies it may 
also be imperative to include phase 
II enzymes as well, as these would 
tend to “deactivate” CYP metabolites 
to more water-soluble and nonreac-
tive compounds. It is also important 
to examine an array of other potential 
prohaptens, others that have been well 
characterized. Validation will be nec-
essary to establish that this CYP cock-
tail has predictive value for ingredient 
screening. With additional work, we 
may be able to establish a databank of 
molecular structures likely to produce 
reactive metabolites.
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